Recent News

• 03.03.2025 - Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
• 02.26.2025 - Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
• 02.26.2025 - Renovaro Announces $15 million in Equity Committed
• 01.07.2025 - Renovaro Appoints Nathen Fuentes as Chief Financial Officer
• 01.07.2025 - Renovaro Issues Shareholder Letter and Provides Corporate Update

Recent Filings

• 02.28.2025 - EX-99.1 EX-99.1
• 02.28.2025 - 8-K Current report
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.19.2025 - 10-Q/A Quarterly report [Sections 13 or 15(d)]
• 02.19.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.19.2025 - 10-Q/A Quarterly report [Sections 13 or 15(d)]
• 02.19.2025 - 8-K Current report
• 02.18.2025 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB